- €67.78m
- €369.23m
- €608.25m
- 43
- 93
- 34
- 59
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 556 | 610 | 439 | 497 | 608 |
Cost of Revenue | |||||
Gross Profit | 132 | 141 | 100 | 108 | 102 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 527 | 581 | 435 | 485 | 611 |
Operating Profit | 29 | 29.2 | 3.87 | 12 | -2.43 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25.3 | 26.7 | -15.6 | 16.1 | -9.58 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17.9 | 19.5 | -26 | 8.14 | -15.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 23.8 | 19.4 | -26.1 | 7.93 | -15.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 23.8 | 19.4 | -26.1 | 7.93 | -15.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.807 | 0.777 | -0.709 | 0.354 | -0.553 |
Dividends per Share | |||||
Special Dividends per Share |